Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Not yet recruiting · NCT05970627 · Registry updated 2023-08-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | Epstein-Barr virus-associated gastric carcinoma, gastric adenocarcinoma | Not yet recruiting | Phase 2 | 2023-08-01 | NCT05970627 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yu jiren | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huzhou Central Hospital | Huzhou | China | 3 |
| Lishui Central Hospital | Lishui | China | 15 |
| Ningbo First Hospital | Ningbo | China | 11 |
| Ningbo Medical Center LiHuiLi Hospital | Ningbo | China | 6 |
| Ningbo Second Hospital | Ningbo | China | 3 |
| Taizhou Hospital | Taizhou | China | 4 |
| The First Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou | China | 12 |
| The Second Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou | China | 4 |